M Gehling1, B Hermann, M Tryba. 1. Dept of Anesthesiology, Intensive Care Medicine and Pain Therapy, Klinikum Kassel GmbH, Moenchebergstr 41-43, 34125 Kassel, Deutschland. gehling@klinikum-kassel.de
Abstract
BACKGROUND: The interpretation of opioid studies in patients with chronic pain due to osteoarthritis is limited by a high dropout rate. Therefore, the implication of dropouts on the recommendation of opioids in chronic osteoarthritis pain was analyzed. DATA SOURCES: The databases of Medline, Embase, the Cochrane Library, and the Internet from 1990-2009 were searched. STUDY SELECTION: Two independent authors included randomized controlled clinical trials investigating the effects of chronic opioid treatment for the management of osteoarthritis pain. In order to calculate the odds ratio, only placebo-controlled trials were included. DATA EXTRACTION: The primary outcome parameter was the dropout rate. Secondarily, the effect size was calculated. Data extraction was conducted by two independent authors. RESULTS: A total of 19 studies reporting results of 3,871 treatment and 2,080 placebo outcomes were retrieved. Compared to placebo, opioid treatment was associated with a significantly increased total dropout rate (OR = 1.3, 95%CI 1.2-1.4). Discontinuation of treatment was related to adverse events (OR = 4.0, 95%CI 3.4-4.6). Lack of analgesia was associated with a significantly reduced dropout rate in opioid groups (OR = 0.4, 95%CI 0.3-0.5). Analgesic effects were significantly better in opioid-treated patients (p = 0.01). CONCLUSION: In spite of analgesic effects, many osteoarthritis patients prefer to stop chronic opioid use, because of adverse events. Therefore, opioids are not generally recommended in osteoarthritis.
BACKGROUND: The interpretation of opioid studies in patients with chronic pain due to osteoarthritis is limited by a high dropout rate. Therefore, the implication of dropouts on the recommendation of opioids in chronic osteoarthritis pain was analyzed. DATA SOURCES: The databases of Medline, Embase, the Cochrane Library, and the Internet from 1990-2009 were searched. STUDY SELECTION: Two independent authors included randomized controlled clinical trials investigating the effects of chronic opioid treatment for the management of osteoarthritis pain. In order to calculate the odds ratio, only placebo-controlled trials were included. DATA EXTRACTION: The primary outcome parameter was the dropout rate. Secondarily, the effect size was calculated. Data extraction was conducted by two independent authors. RESULTS: A total of 19 studies reporting results of 3,871 treatment and 2,080 placebo outcomes were retrieved. Compared to placebo, opioid treatment was associated with a significantly increased total dropout rate (OR = 1.3, 95%CI 1.2-1.4). Discontinuation of treatment was related to adverse events (OR = 4.0, 95%CI 3.4-4.6). Lack of analgesia was associated with a significantly reduced dropout rate in opioid groups (OR = 0.4, 95%CI 0.3-0.5). Analgesic effects were significantly better in opioid-treated patients (p = 0.01). CONCLUSION: In spite of analgesic effects, many osteoarthritispatients prefer to stop chronic opioid use, because of adverse events. Therefore, opioids are not generally recommended in osteoarthritis.
Authors: Jacques R Caldwell; Ronald J Rapoport; Jeffrey C Davis; Howard L Offenberg; Howard W Marker; Sanford H Roth; William Yuan; Lise Eliot; Najib Babul; Pia Mikkelsen Lynch Journal: J Pain Symptom Manage Date: 2002-04 Impact factor: 3.612
Authors: Vishala L Chindalore; Richard A Craven; K Peony Yu; Peter G Butera; Lindsay H Burns; Nadav Friedmann Journal: J Pain Date: 2005-06 Impact factor: 5.820
Authors: Y Harati; C Gooch; M Swenson; S Edelman; D Greene; P Raskin; P Donofrio; D Cornblath; R Sachdeo; C O Siu; M Kamin Journal: Neurology Date: 1998-06 Impact factor: 9.910
Authors: Nicholas Fuggle; Elizabeth Curtis; Sarah Shaw; Laura Spooner; Olivier Bruyère; Georgia Ntani; Camille Parsons; Philip G Conaghan; Nadia Corp; Germain Honvo; Daniel Uebelhart; Janis Baird; Elaine Dennison; Jean-Yves Reginster; Cyrus Cooper Journal: Drugs Aging Date: 2019-04 Impact factor: 3.923
Authors: Agnes J Smink; Sita M A Bierma-Zeinstra; Joost Dekker; Thea P M Vliet Vlieland; Johannes W J Bijlsma; Bart A Swierstra; Joke H Kortland; Theo B Voorn; Cornelia H M van den Ende; Henk J Schers Journal: BMC Fam Pract Date: 2013-03-11 Impact factor: 2.497